ArticleBreast cancer (Tokyo, Japan)2025
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey.
Article in Breast cancer (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions.Breast cancer (Tokyo, Japan) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundTime toxicity in breast cancer refers to the time burden patients face from treatments, hospital visits, and managing side effects. As survival improves, attention has shifted to the impact of time spent on care. For those receiving long-term endocrine therapy, visiting hospital and waiting time for clinic affect their daily life. Thus, reducing time toxicity is essential to improve quality of life alongside survival outcomes.
methodsThis study surveyed postoperative breast cancer patients requiring hormonal therapy, who attended Yokohama City University Hospital from August 2023 to July 2024, using a digital self-administered survey to assess prescription refills. The Hospital Anxiety and Depression Scale and the original questionnaire were used to compare changes in status of patients before and after the introduction of prescription refills.
resultsA comparison of outpatient visits before and after prescription refills revealed a decreasing trend in visit frequency. Patient satisfaction showed a significant improvement, with patients giving higher ratings after prescription refills were introduced. The proportion of patients experiencing shorter waits increased, with 49% reporting a reduction in waiting times. Anxiety about extended visit intervals decreased, with only 1% of patients reporting increased anxiety. Notably, patient satisfaction with prescription refills remained high across various postoperative durations and age groups. Approximately 70% of patients expressed a desire to continue using prescription refills, indicating overall positive reception regardless of age or postoperative period.
conclusionThe introduction of prescription refills led to a reduction in outpatient visits and improvements in patient satisfaction and perceived waiting times. Prescription refills, recently introduced in Japan, are not yet widely recognized but may become a valuable tool for breast cancer patients and healthcare providers. Further research is required to assess the impact of the prescription refills on patient outcomes.
Indexed as
Identifiers
40856977What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.